Jake Kraft
Jake Kraft is Co-founder and Chief Executive Officer at Lila Bio. He was Acting Instructor and Translational Investigator at the Institute for Protein Design, University of Washington, and Founder at Qualtonomy.
Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed long‑acting injectable for pulmonary hypertension
Lila Bio, spun out of David Baker’s UW lab, won a $3.65 million NIH SBIR grant to develop an AI-designed, long-acting injectable protein therapy aimed at modifying disease in pulmonary hypertension. The funding covers two phases—$605,981 for initial animal studies and $3,049,462 for further animal work and patient lung-tissue studies—and builds on Lila’s 2023 $10M seed raise and prior collaboration with Eli Lilly.
Lila Bio wins $3.65M NIH SBIR grant to build AI-designed proteins for pulmonary hypertension
Lila Bio won a $3.65 million NIH SBIR fast-track grant to develop AI-designed therapeutic proteins for pulmonary hypertension, receiving an initial $605,981 phase followed by $3,049,462 in a second phase. The Seattle startup, founded in 2023 by Jake Kraft and Anindya Roy, previously raised a $10 million seed round and will use the non-dilutive funding to advance candidates toward clinical utility.
Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed protein therapy for pulmonary hypertension
Lila Bio received a $3.65 million NIH SBIR grant to develop AI-designed, long-acting injectable protein therapies that aim to modify the underlying disease in pulmonary hypertension; initial work is in lab and animal testing with further studies planned using patient lung tissue.
See all 5 stories, episodes and videos about Jake Kraft.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 8-
Lila Bio CEO & Co-Founder 2023–present · current
-
Institute for Protein Design, University of Washington Acting Instructor, Translational Investigator 2023, Translational Postdoc 2022–2023, Senior Postdoctoral Fellow 2018–2022 · past
-
University of Washington Pharmaceutics PhD Student 2013–2018, Research Scientist 2013, Book Editor 2012–2013, Research Study Assistant 2008–2011 · past
Education
-
University of Washington Doctor of Philosophy - PhD, Pharmaceutics · 2013–2018
-
The University of Kansas BS, Chemistry · 2004–2007
-
Institute for American Universities (IAU) French · 2004
-
University of San Diego 2002–2004